SCHEMBL5317364

SCHEMBL5317364

OCCCCCc1nn(Cc2ccc(Cl)cc2Cl)c2cc(C(F)(F)F)ccc12

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
TSHR P16473 1/20 0.41
PMP22 Q01453 1/20 0.41
HIF1A Q16665 1/20 0.41
AKR1B1 P15121 1/20 0.38
NPC1 O15118 1/20 0.36
SLC9A1 P19634 1/20 0.35
PPARG P37231 3/20 0.35
LMNA P02545 1/20 0.35
SLC22A12 Q96S37 1/20 0.35
MC4R P32245 1/20 0.35
NR1H2 P55055 1/20 0.34
NR1H3 Q13133 1/20 0.34
CCR2 P41597 1/20 0.34
ENPP2 Q13822 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5322190 0.99 NPSR1 (0.41) NPSR1CYP2C9CYP1A2CYP3A4CYP2D6
SCHEMBL5316051 0.96 NPSR1 (0.42) NPSR1CYP2C9CYP1A2CYP3A4CYP2D6
SCHEMBL5318892 0.92 CYP2C9 (0.43) NPSR1CYP2C9CYP1A2CYP3A4CYP2D6
SCHEMBL5273263 0.91 NR1H2 (0.41) CYP2C9CYP3A4CYP2D6AKR1B1SLC22A12
SCHEMBL5322327 0.91 NR1H2 (0.41) PPARGLMNASLC22A12NR1H2NR1H3
SCHEMBL5317869 0.90 AKR1B1 (0.37) NPSR1CYP2C9AKR1B1SLC22A12MC4R
SCHEMBL5318908 0.90 NR1H2 (0.42) CYP2C9CYP3A4CYP2D6AKR1B1SLC22A12
SCHEMBL5322373 0.90 NR1H2 (0.41) PPARGLMNASLC22A12NR1H2NR1H3
SCHEMBL5317649 0.89 AKR1B1 (0.38) NPSR1CYP2C9AKR1B1SLC22A12MC4R
SCHEMBL5317347 0.87 CYP1A2 (0.45) NPSR1CYP2C9CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1786424-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT The University of Kansas (US) 2007-05-23 EP claimed
WO-2006023704-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT UNIVERSITY OF KANSAS (US) 2006-03-02 WO claimed